76 related articles for article (PubMed ID: 19638095)
1. Education and Imaging. Hepatobiliary and pancreatic: malignant wash-out pattern of hepatocellular cancer using dynamic MR imaging.
Cubuk R; Tasali N
J Gastroenterol Hepatol; 2009 Jun; 24(6):1151. PubMed ID: 19638095
[No Abstract] [Full Text] [Related]
2. Paradoxical high signal intensity of hepatocellular carcinoma in the hepatobiliary phase of Gd-EOB-DTPA enhanced MRI: initial experience.
Lee SA; Lee CH; Jung WY; Lee J; Choi JW; Kim KA; Park CM
Magn Reson Imaging; 2011 Jan; 29(1):83-90. PubMed ID: 20832227
[TBL] [Abstract][Full Text] [Related]
3. [Dynamic MRI].
Araki T; Ichikawa T; Nakajima H
Nihon Rinsho; 2001 Oct; 59 Suppl 6():292-5. PubMed ID: 11761959
[No Abstract] [Full Text] [Related]
4. Evolution of hypointense hepatocellular nodules observed only in the hepatobiliary phase of gadoxetate disodium-enhanced MRI.
Kumada T; Toyoda H; Tada T; Sone Y; Fujimori M; Ogawa S; Ishikawa T
AJR Am J Roentgenol; 2011 Jul; 197(1):58-63. PubMed ID: 21701011
[TBL] [Abstract][Full Text] [Related]
5. Contrast-enhanced dynamic magnetic resonance imaging findings of hepatocellular carcinoma and their correlation with histopathologic findings.
Karahan OI; Yikilmaz A; Artis T; Canoz O; Coskun A; Torun E
Eur J Radiol; 2006 Mar; 57(3):445-52. PubMed ID: 16337762
[TBL] [Abstract][Full Text] [Related]
6. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.
Sun HY; Lee JM; Shin CI; Lee DH; Moon SK; Kim KW; Han JK; Choi BI
Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319
[TBL] [Abstract][Full Text] [Related]
7. Primary hepatocellular lesions: imaging findings on state-of-the-art magnetic resonance imaging, with pathologic correlation.
van den Bos IC; Hussain SM; de Man RA; Zondervan PE; Ijzermans JN; Krestin GP
Curr Probl Diagn Radiol; 2008; 37(3):104-14. PubMed ID: 18436110
[TBL] [Abstract][Full Text] [Related]
8. Small hypervascular hepatocellular carcinoma: limited value of portal and delayed phases on dynamic magnetic resonance imaging.
Yu JS; Lee JH; Chung JJ; Kim JH; Kim KW
Acta Radiol; 2008 Sep; 49(7):735-43. PubMed ID: 18608015
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of Gd-BOPTA and Gd-DTPA in contrast-enhanced MR imaging of the liver].
Zhang HM; Ouyang H; Zhou CW
Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):111-5. PubMed ID: 16750014
[TBL] [Abstract][Full Text] [Related]
10. Contrast enhanced MR-guided biopsy of hepatocellular carcinoma.
König CW; Trübenbach J; Fritz J; Lauer UM; Claussen CD; Pereira PL
Abdom Imaging; 2004; 29(1):71-6. PubMed ID: 15160756
[TBL] [Abstract][Full Text] [Related]
11. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
[TBL] [Abstract][Full Text] [Related]
12. Detection of viable tumor cells in hepatocellular carcinoma following transcatheter arterial chemoembolization with iodized oil. Pathologic correlation with dynamic turbo-FLASH MR imaging with Gd-DTPA.
Murakami T; Nakamura H; Hori S; Tomoda K; Mitani T; Nakanishi K; Hashimoto T; Tsuda K; Kozuka T; Monden M
Acta Radiol; 1993 Jul; 34(4):399-403. PubMed ID: 8391291
[TBL] [Abstract][Full Text] [Related]
13. MR imaging of hepatocellular carcinoma: relationship between lesion size and imaging findings, including signal intensity and dynamic enhancement patterns.
van den Bos IC; Hussain SM; Dwarkasing RS; Hop WC; Zondervan PE; de Man RA; IJzermans JN; Walker CW; Krestin GP
J Magn Reson Imaging; 2007 Dec; 26(6):1548-55. PubMed ID: 17968956
[TBL] [Abstract][Full Text] [Related]
14. [The dynamic magnetic resonance study of focal liver lesions by FLASH sequences with bolus intravenous gadolinium-DTPA].
Olivetti L; Grazioli L; Maroldi R; Matricardi L; Milanesio L
Radiol Med; 1992 Apr; 83(4):353-60. PubMed ID: 1318558
[TBL] [Abstract][Full Text] [Related]
15. The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma.
Kamel IR; Bluemke DA; Eng J; Liapi E; Messersmith W; Reyes DK; Geschwind JF
J Vasc Interv Radiol; 2006 Mar; 17(3):505-12. PubMed ID: 16567675
[TBL] [Abstract][Full Text] [Related]
16. Relationship between liver function and liver signal intensity in hepatobiliary phase of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging.
Tajima T; Takao H; Akai H; Kiryu S; Imamura H; Watanabe Y; Shibahara J; Kokudo N; Akahane M; Ohtomo K
J Comput Assist Tomogr; 2010; 34(3):362-6. PubMed ID: 20498536
[TBL] [Abstract][Full Text] [Related]
17. The value of gadobenate dimeglumine-enhanced hepatobiliary-phase MR imaging for the differentiation of scirrhous hepatocellular carcinoma and cholangiocarcinoma with or without hepatocellular carcinoma.
Jeon TY; Kim SH; Lee WJ; Lim HK
Abdom Imaging; 2010 Jun; 35(3):337-45. PubMed ID: 19350315
[TBL] [Abstract][Full Text] [Related]
18. MR-guided ablation of hepatocellular carcinoma aided by gadoxetic acid.
Bathe OF; Mahallati H
J Surg Oncol; 2007 Jun; 95(8):670-3. PubMed ID: 17345591
[TBL] [Abstract][Full Text] [Related]
19. Education and imaging. Hepatobiliary and Pancreatic: Detection of early hepatocellular carcinoma by enhanced magnetic resonance imaging.
Eso Y; Marusawa H; Osaki Y
J Gastroenterol Hepatol; 2012 Feb; 27(2):416. PubMed ID: 22260287
[No Abstract] [Full Text] [Related]
20. Cirrhosis: spectrum of findings on unenhanced and dynamic gadolinium-enhanced MR imaging.
Vitellas KM; Tzalonikou MT; Bennett WF; Vaswani KK; Bova JG
Abdom Imaging; 2001; 26(6):601-15. PubMed ID: 11907725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
